Inceptionr LLC Reduces Holdings in Amdocs Limited $DOX

Inceptionr LLC decreased its position in shares of Amdocs Limited (NASDAQ:DOX) by 84.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 3,742 shares of the technology company’s stock after selling 20,249 shares during the quarter. Inceptionr LLC’s holdings in Amdocs were worth $307,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Pzena Investment Management LLC lifted its holdings in Amdocs by 0.6% during the third quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock valued at $540,976,000 after purchasing an additional 42,184 shares during the last quarter. LSV Asset Management increased its stake in shares of Amdocs by 7.6% in the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock worth $299,376,000 after purchasing an additional 257,193 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of Amdocs by 3.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,111,312 shares of the technology company’s stock valued at $252,856,000 after purchasing an additional 91,428 shares during the period. Vanguard Group Inc. raised its position in shares of Amdocs by 0.3% in the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock valued at $251,602,000 after purchasing an additional 9,207 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Amdocs by 7.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,332,381 shares of the technology company’s stock valued at $191,366,000 after buying an additional 160,040 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Price Performance

Shares of NASDAQ:DOX opened at $66.92 on Friday. The firm has a fifty day moving average price of $75.35 and a two-hundred day moving average price of $79.38. The company has a market cap of $7.22 billion, a price-to-earnings ratio of 12.94, a PEG ratio of 1.18 and a beta of 0.42. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.06. Amdocs Limited has a one year low of $65.74 and a one year high of $95.41.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.06. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be issued a $0.569 dividend. This represents a $2.28 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is an increase from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s payout ratio is 40.81%.

Analysts Set New Price Targets

Several research analysts recently commented on DOX shares. Wolfe Research reaffirmed a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Stifel Nicolaus dropped their target price on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Barclays cut their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $92.33.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.